Overview

Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers

Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
To compare the efficacy of XDEMVY ophthalmic drop to its vehicle control for the treatment of Demodex blepharitis and its impact on the soft contact lens wearing experience.
Phase:
Phase 4
Details
Lead Sponsor:
Tarsus Pharmaceuticals, Inc.
Treatments:
Ophthalmic Solutions